SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS

Abstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. A. Chumakov, O. A. Pronina, I. A. Kachkov, A. G. Korshounov, B. V. Pineguin, I. I. Anan’eva, T. Elbeik, L. S. Metelitsa, A. E. Dorofeev, N. V. Gnouchev, S. V. Souchkov
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/0d85015c494a4ec09bab63f483d9478f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0d85015c494a4ec09bab63f483d9478f
record_format dspace
spelling oai:doaj.org-article:0d85015c494a4ec09bab63f483d9478f2021-11-18T08:03:40ZSPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS1563-06252313-741X10.15789/1563-0625-2006-1-37-50https://doaj.org/article/0d85015c494a4ec09bab63f483d9478f2014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/424https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAbstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in patients with different forms of GB can be of pathogenetic importance and have clinical value for treatment and rehabilitation scheduling as well. The most pathogenically and clinically important features of cell subsets profile of peripheral blood were analyzed in patients with different clinical and morphological types of GB. The patients were divided into three groups, i.e., groups I and II were formed by patients with STASID (marked and slightly marked SID, accordingly); group III – patients with SIDTAS (tumor-associated autoimmune syndrome, associated with SID). Marked suppression of cell immunity is typical of group I - imbalance in T-lymphocytes, in a number of specific subsets, and in subsets clusters, as well as disproportions in the immunoregulatory indexes. In group II, the subset profiles of blood were slightly different from the norm. In patients with SIDTAS, activation of cell immunity was evident, forming SID with signs of autoimmune syndrome, affecting effector and regulatory chains of immunity, and influencing the severity and forecast of the disease. Specific features of the immune status in patients with GB identified can be resulted from different clinicalmorphological types of the tumor; the latter are to be considered in differential diagnostics of clinical course of GB and in scheduling of clinical-immunological efficient anti-tumor pharmacotherapy in pre- and postoperative periods.V. A. ChumakovO. A. ProninaI. A. KachkovA. G. KorshounovB. V. PineguinI. I. Anan’evaT. ElbeikL. S. MetelitsaA. E. DorofeevN. V. GnouchevS. V. SouchkovSPb RAACIarticleglioblastomasecondary immunodeficiencyautoimmune syndromelympholytes subpopulationsanti-tumor immunityImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 8, Iss 1, Pp 37-50 (2014)
institution DOAJ
collection DOAJ
language RU
topic glioblastoma
secondary immunodeficiency
autoimmune syndrome
lympholytes subpopulations
anti-tumor immunity
Immunologic diseases. Allergy
RC581-607
spellingShingle glioblastoma
secondary immunodeficiency
autoimmune syndrome
lympholytes subpopulations
anti-tumor immunity
Immunologic diseases. Allergy
RC581-607
V. A. Chumakov
O. A. Pronina
I. A. Kachkov
A. G. Korshounov
B. V. Pineguin
I. I. Anan’eva
T. Elbeik
L. S. Metelitsa
A. E. Dorofeev
N. V. Gnouchev
S. V. Souchkov
SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
description Abstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in patients with different forms of GB can be of pathogenetic importance and have clinical value for treatment and rehabilitation scheduling as well. The most pathogenically and clinically important features of cell subsets profile of peripheral blood were analyzed in patients with different clinical and morphological types of GB. The patients were divided into three groups, i.e., groups I and II were formed by patients with STASID (marked and slightly marked SID, accordingly); group III – patients with SIDTAS (tumor-associated autoimmune syndrome, associated with SID). Marked suppression of cell immunity is typical of group I - imbalance in T-lymphocytes, in a number of specific subsets, and in subsets clusters, as well as disproportions in the immunoregulatory indexes. In group II, the subset profiles of blood were slightly different from the norm. In patients with SIDTAS, activation of cell immunity was evident, forming SID with signs of autoimmune syndrome, affecting effector and regulatory chains of immunity, and influencing the severity and forecast of the disease. Specific features of the immune status in patients with GB identified can be resulted from different clinicalmorphological types of the tumor; the latter are to be considered in differential diagnostics of clinical course of GB and in scheduling of clinical-immunological efficient anti-tumor pharmacotherapy in pre- and postoperative periods.
format article
author V. A. Chumakov
O. A. Pronina
I. A. Kachkov
A. G. Korshounov
B. V. Pineguin
I. I. Anan’eva
T. Elbeik
L. S. Metelitsa
A. E. Dorofeev
N. V. Gnouchev
S. V. Souchkov
author_facet V. A. Chumakov
O. A. Pronina
I. A. Kachkov
A. G. Korshounov
B. V. Pineguin
I. I. Anan’eva
T. Elbeik
L. S. Metelitsa
A. E. Dorofeev
N. V. Gnouchev
S. V. Souchkov
author_sort V. A. Chumakov
title SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
title_short SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
title_full SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
title_fullStr SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
title_full_unstemmed SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
title_sort specificities of the subset profile of peripheral blood in patients with glioblastoma: pathogenetic and clinical assessments
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/0d85015c494a4ec09bab63f483d9478f
work_keys_str_mv AT vachumakov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT oapronina specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT iakachkov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT agkorshounov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT bvpineguin specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT iiananeva specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT telbeik specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT lsmetelitsa specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT aedorofeev specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT nvgnouchev specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
AT svsouchkov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments
_version_ 1718422524505620480